Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Skin Diseases, Papulosquamous 1Skin Diseases 1Sarcoma, Synovial 1Sarcoma 1Psoriasis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Plaque, Amyloid 1Myelodysplastic Syndromes 1Lymphoma, Follicular 1Lymphoma 1Liposarcoma, Myxoid 1Leukemia, Myeloid, Acute 1Leukemia, Biphenotypic, Acute 1Leiomyosarcoma 1Histiocytoma, Malignant Fibrous 1Graft vs Host Disease 1Chondrosarcoma 1Bronchiolitis Obliterans Syndrome 1Arthritis, Rheumatoid 1Adenoma, Liver Cell 1

Interventions

Doxorubicin 17Cyclophosphamide 15Ifosfamide 11fludarabine 8Radiotherapy 8tazemetostat 4pembrolizumab 4pazopanib 4Gemcitabine 4pegfilgrastim 3cixutumumab 3Trabectedin 3Radiation 3Imatinib Mesylate 3Filgrastim 3Docetaxel 3Dacarbazine 3sargramostim 2liposomal doxorubicin 2fludarabine phosphate 2brostallicin 2aldesleukin 2X-Rays 2Sunitinib 2Specimen Handling 2Sorafenib 2Radiation Dose Hypofractionation 2Nivolumab 2Magnetic Resonance Spectroscopy 2Leukapheresis 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Sarcoma, Synovial × baricitinib × Clear all
NCT03670069 2024-05-08

Itacitinib in Treating Patients With Refractory Metastatic/Advanced Sarcomas

Fred Hutchinson Cancer Center

Phase 1 Terminated
27 enrolled
Sarcoma

Chondrosarcoma, Leiomyosarcoma, Sarcoma, Sarcoma, Synovial, Liposarcoma, Myxoid, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡